Obstetrics and Gynecology

1046 questions

Question 821Question →

For each patient presenting with vaginal or cervical symptoms, select the most appropriate management plan regarding antimicrobial therapy and sexual partner evaluation.

Click a left item, then click its matching right item

Items

A 25-year-old woman presents with severe vaginal itching and a thick, cottage-cheese-like discharge. Examination reveals vulvovaginal erythema and a vaginal pH of 4.2.
A 30-year-old woman reports a fishy vaginal odor that worsens after intercourse. Speculum examination shows a thin, homogeneous, grayish-white discharge, and clue cells are seen on saline microscopy.
A 22-year-old woman complains of copious, frothy, yellow-green vaginal discharge and dyspareunia. Examination reveals a 'strawberry cervix' and motile organisms with flagella on wet mount.
A 27-year-old woman presents with intermenstrual bleeding and dysuria. Examination shows mucopurulent discharge at the cervical os and easily induced cervical bleeding on contact, with numerous leukocytes on wet mount but no identifiable organisms.

Matches

Show answer & explanation

Answer

Vulvovaginal candidiasis matches with fluconazole (no partner treatment). Bacterial vaginosis matches with metronidazole (no partner treatment). Trichomoniasis matches with metronidazole (partner treatment required). Acute cervicitis matches with ceftriaxone and doxycycline (partner treatment required).
Each patient's clinical presentation corresponds directly to a specific gynecologic infection with clear guidelines for both the patient's pharmacotherapy and the management of their sexual partners. Distinguishing between dysbiosis (BV, VVC) which does not require partner treatment, and true STIs (trichomoniasis, cervicitis) which mandate partner treatment, is a critical clinical skill.

Step-by-Step Solution

1
Analyze the first clinical presentation to identify the specific gynecologic condition.
Thick white discharge with intense pruritus and normal pH (4.2) indicates vulvovaginal candidiasis (VVC).
Accurate diagnosis based on symptom profile and pH is required to select appropriate pharmacotherapy.
2
Determine the treatment and partner management guidelines for VVC.
VVC requires antifungal therapy (e.g., fluconazole) but is not a sexually transmitted infection, so partner treatment is unnecessary.
Antimicrobial stewardship and current guidelines dictate not treating partners for fungal overgrowth.
3
Analyze the second presentation to identify the condition.
Thin, malodorous discharge, clue cells, and an elevated pH (5.5) are diagnostic for bacterial vaginosis (BV).
Clue cells and a positive whiff test (fishy odor) are classic Amsel criteria for BV.
4
Determine the treatment and partner management for BV.
BV is treated with metronidazole. Partner treatment has not been shown to prevent recurrence and is not recommended.
Treating male partners for BV does not alter the clinical course for the female patient and unnecessarily exposes the partner to antibiotics.
5
Identify the condition in the third presentation.
Frothy, yellow-green discharge, a 'strawberry cervix,' and motile organisms on wet mount indicate Trichomonas vaginalis.
Direct visualization of motile flagellated protozoa confirms trichomoniasis.
6
Establish the management protocol for Trichomoniasis.
Trichomoniasis requires systemic metronidazole. As a highly contagious STI, partner treatment is absolutely required to prevent reinfection.
Untreated partners are the primary cause of recurrent Trichomonas infections.
7
Evaluate the fourth clinical presentation.
Mucopurulent discharge, cervical friability, and numerous leukocytes without visible organisms indicate acute cervicitis (presumptive gonorrhea/chlamydia).
These findings are classic for cervical inflammation caused by intracellular or fastidious pathogens not visible on standard wet mount.
8
Determine empiric treatment for acute cervicitis.
Empiric coverage includes ceftriaxone (for N. gonorrhoeae) and doxycycline (for C. trachomatis). As these are STIs, partner evaluation and treatment are mandatory.
Immediate empiric treatment for both major pathogens is standard of care while awaiting NAAT results, along with partner therapy.

Key Concept

Differentiation of common vaginal and cervical infections by clinical presentation and their specific management protocols, particularly distinguishing when sexual partner treatment is indicated (STIs) versus when it is not (dysbiosis/overgrowth).
Question 822Question →

Match each standard prenatal screening test or intervention with the gestational age window during which it is universally indicated for an average-risk, uncomplicated pregnancy.

Click a left item, then click its matching right item

Items

Initial prenatal visit (typically < 10 weeks gestation)
15 to 22 weeks gestation
24 to 28 weeks gestation
35 to 37 weeks gestation

Matches

Show answer & explanation

Answer

The initial visit matches with the urine culture for asymptomatic bacteriuria. The 15 to 22-week window matches with MSAFP quantification. The 24 to 28-week window matches with the 50-g glucose challenge test. The 35 to 37-week window matches with the rectovaginal swab for GBS.
Routine prenatal care follows a strict, evidence-based timeline. Baseline labs (including a urine culture for asymptomatic bacteriuria, CBC, HIV, RPR, and blood typing) are drawn at the initial visit. Second-trimester screening (15-22 weeks) focuses on fetal anatomic and genetic markers, notably MSAFP for neural tube defects. The 24-28 week window targets gestational diabetes screening because the secretion of human placental lactogen (hPL), which induces insulin resistance, reaches peak clinical relevance. Finally, 35-37 weeks is the optimal time for GBS screening, as results are considered valid for 5 weeks, perfectly aligning with the anticipated onset of term labor.

Step-by-Step Solution

1
Determine the universal screening indicated at the first prenatal visit.
Urine culture is matched to the initial visit.
Early detection of asymptomatic bacteriuria is critical to prevent progression to pyelonephritis, which is a significant risk due to pregnancy-induced urinary stasis.
2
Identify the primary screening test performed in the early second trimester (15-22 weeks).
MSAFP quantification is matched to the 15-22 week window.
This is the standard window for neural tube defect screening, often performed as part of the quadruple marker screen.
3
Identify the universal screening test indicated at the end of the second trimester (24-28 weeks).
The 50-g, 1-hour glucose challenge test is matched to the 24-28 week window.
Maternal insulin resistance driven by placental hormones becomes clinically significant at this stage, making it the optimal time to screen for gestational diabetes.
4
Determine the final routine screening test performed in the late third trimester (35-37 weeks).
The rectovaginal swab for GBS is matched to the 35-37 week window.
GBS colonization can come and go, so testing must occur close to term to accurately guide intrapartum antibiotic prophylaxis.

Key Concept

Chronology of Routine Prenatal Screening
Question 823Question →

During a routine prenatal visit, a 30-year-old woman at 34 weeks gestation reports experiencing episodes of lightheadedness, nausea, and a feeling of impending fainting over the past two weeks. She states that these episodes occur exclusively when she is lying flat on her back. The symptoms resolve rapidly when she turns onto her side. Her pregnancy has been uncomplicated. Her blood pressure is 112/68 mm Hg and her heart rate is 85/min while seated in the clinic. Fetal heart monitoring shows a baseline rate of 145/min with moderate variability and no decelerations. Which of the following is the most likely underlying mechanism for this patient's symptoms?

Show answer & explanation

Answer: Decreased venous return due to inferior vena cava compression

Answer

The symptoms are caused by decreased venous return due to inferior vena cava compression.
The correct answer accurately describes the pathophysiology of supine hypotensive syndrome. In the third trimester, the heavy, gravid uterus mechanically compresses the inferior vena cava when the patient lies in the supine position. This compression impedes venous return to the right atrium, leading to a transient decrease in cardiac output and subsequent cerebral hypoperfusion. Patients characteristically present with lightheadedness, nausea, and presyncope when lying flat. Symptoms rapidly resolve when the patient turns to a lateral decubitus position, which displaces the uterus off the inferior vena cava and restores normal venous return.

Step-by-Step Solution

1
Identify the patient's key clinical presentation and its positional nature.
The patient is in her third trimester and experiences lightheadedness and nausea exclusively when lying flat, which resolves upon turning to her side.
To establish that the symptoms are strictly positional and related to the supine posture.
2
Correlate the symptoms with the anatomic and physiologic changes of late pregnancy.
In the third trimester, the enlarged, heavy gravid uterus occupies significant space in the abdomen and can mechanically compress retroperitoneal structures depending on maternal posture.
To determine the underlying pathophysiology of the positional presyncope.
3
Determine the specific vascular structure affected and its hemodynamic consequence.
The supine position causes the gravid uterus to compress the inferior vena cava, impeding venous return to the right atrium and thereby transiently lowering cardiac output.
To accurately identify the mechanism of supine hypotensive syndrome.

Key Concept

Supine hypotensive syndrome in pregnancy is caused by mechanical compression of the inferior vena cava by the gravid uterus, leading to decreased venous return and transient cerebral hypoperfusion.
Question 824Question →

A 33-year-old woman, gravida 2, para 1, is evaluated in the birthing center at 39 weeks of gestation. She is undergoing a trial of labor after a previous low transverse cesarean delivery. Her prenatal course was uncomplicated. She is currently in the active phase of the first stage of labor, with contractions previously occurring every 3 minutes. Suddenly, the patient reports a sharp, continuous, tearing lower abdominal pain that is distinctly different from her previous contraction pain. Continuous fetal monitoring shows a sudden, prolonged deceleration with a baseline drop to 75/min for the past 4 minutes, and uterine contractions have ceased on the tocodynamometer. A sterile vaginal examination reveals the cervix is 7 cm dilated, and the fetal presenting part, which was previously at 0 station, is no longer palpable. Maternal blood pressure is 90/50 mm Hg and heart rate is 120/min. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Immediate laparotomy and cesarean delivery

Answer

Immediate laparotomy and cesarean delivery
The correct answer is immediate laparotomy and cesarean delivery. This patient's presentation is pathognomonic for uterine rupture. She is undergoing a trial of labor after a previous cesarean delivery, which is the primary risk factor. The classic triad includes sudden, severe tearing abdominal pain, an abnormal fetal heart rate tracing (most commonly bradycardia or deep variable decelerations), and a loss of fetal station on vaginal examination. Additionally, the cessation of uterine contractions on the monitor and maternal hemodynamic instability (hypotension and tachycardia) indicate severe internal hemorrhage. Immediate surgical exploration is required to deliver the fetus, control maternal bleeding, and repair or remove the ruptured uterus.

Step-by-Step Solution

1
Analyze the patient's risk factors and acute clinical presentation.
The patient is undergoing a trial of labor after cesarean (TOLAC) and presents with sudden tearing pain, maternal hypotension, tachycardia, and a prolonged fetal heart rate deceleration.
Identifying the intersection of risk factors (prior uterine scar) and acute signs of shock/fetal distress is essential for diagnosis.
2
Interpret the physical examination findings.
The sudden cessation of uterine contractions on the tocodynamometer and the loss of fetal station (from 0 to unpalpable) are highly specific for uterine rupture.
When the uterus ruptures, it loses its ability to contract effectively, and the fetus can retract upward into the maternal abdomen.
3
Determine the necessary clinical intervention.
The patient requires immediate surgical exploration and delivery to control maternal hemorrhage and rescue the fetus.
Uterine rupture is an acute obstetric emergency; conservative or diagnostic delays significantly increase maternal and perinatal morbidity and mortality.

Key Concept

Uterine rupture is a catastrophic complication of labor, classically presenting with sudden abdominal pain, loss of fetal station, cessation of contractions, and fetal compromise, requiring emergent laparotomy.
Estimated Time:1m 15s
Question 825Question →

A 2626-year-old woman comes to the office due to the absence of menstrual periods for the past 77 months. Previously, she had regular 2828-day cycles with normal bleeding. Over the same 77-month period, she has noticed worsening acne, increased thick hair growth on her face and abdomen, and a deepening of her voice. She has no significant past medical history and takes no medications. A urine pregnancy test obtained in the clinic is negative. Vital signs are temperature 36.8∘C36.8^\circ\text{C}, blood pressure 122/78 mmHg122/78 \text{ mmHg}, pulse 76/min76/\text{min}, and respirations 14/min14/\text{min}. BMI is 24 kg/m224 \text{ kg/m}^2. Physical examination reveals temporal hair thinning and terminal hair on the upper lip, chin, and linea alba. Pelvic examination shows clitoromegaly and a normal-sized, mobile uterus. Adnexae are difficult to palpate. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Measurement of serum testosterone and dehydroepiandrosterone sulfate

Answer

Measurement of serum testosterone and dehydroepiandrosterone sulfate
The correct answer identifies that the patient is experiencing rapid-onset virilization, evidenced by clitoromegaly, a deepened voice, and temporal hair thinning over just 77 months. While hirsutism (increased body hair) can be seen in benign conditions like PCOS, true virilization is a red flag for an androgen-secreting tumor (ovarian or adrenal). The most appropriate next step in management is measuring serum testosterone and dehydroepiandrosterone sulfate (DHEAS) levels to differentiate between an ovarian and adrenal source before proceeding with targeted imaging.

Step-by-Step Solution

1
Analyze the patient's presenting symptoms and timeline.
The patient has secondary amenorrhea and rapid-onset virilization (clitoromegaly, deepening voice, temporal hair thinning) that developed over a short 77-month period.
Establishing the pace and severity of symptom onset helps differentiate between benign hyperandrogenic states and malignant causes.
2
Differentiate the clinical picture from common benign etiologies like Polycystic Ovary Syndrome (PCOS).
PCOS typically presents with mild hirsutism and irregular menses starting around puberty with a slow, progressive course. True virilization (clitoromegaly, male-pattern balding, deepened voice) strongly points away from PCOS.
Rapid virilization in a reproductive-aged woman is the hallmark presentation of an androgen-secreting tumor.
3
Determine the next best step to investigate the suspected etiology.
Immediate biochemical localization of the androgen source using serum testosterone (typically elevated in ovarian tumors) and dehydroepiandrosterone sulfate (DHEAS) (typically elevated in adrenal tumors) is required.
Biochemical testing guides subsequent appropriate imaging (pelvic ultrasound vs. abdominal CT) to locate the mass.

Key Concept

Secondary amenorrhea accompanied by rapid-onset virilization (e.g., clitoromegaly, deepening voice) is highly suspicious for an androgen-secreting tumor and requires immediate evaluation with serum testosterone and DHEAS levels.
Question 826Question →

During a routine prenatal visit at 24 weeks gestation, a primigravid patient reports new-onset, intense vulvar pruritus accompanied by a thick, white vaginal discharge over the past four days. She recently completed a course of cephalexin for an uncomplicated urinary tract infection. She denies any pelvic pain, uterine contractions, or leakage of fluid. Vital signs are within normal limits. Pelvic examination reveals marked vulvar erythema and a thick, adherent, curd-like discharge in the vaginal vault. The vaginal pH is 4.2. Microscopic evaluation of the vaginal secretions mixed with 10% potassium hydroxide demonstrates budding yeasts and branching tubular structures. Which of the following is the most appropriate management for this patient's current symptoms?

Show answer & explanation

Answer: Intravaginal clotrimazole therapy for 7 days

Answer

Intravaginal clotrimazole therapy for 7 days
The correct answer is intravaginal clotrimazole therapy for 7 days. This patient exhibits classic signs of vulvovaginal candidiasis (VVC), including severe pruritus, a thick, white, curd-like discharge, vulvar erythema, and a normal vaginal pH (less than 4.5). The diagnosis is definitively confirmed by the presence of budding yeasts and pseudohyphae on a potassium hydroxide (KOH) preparation. VVC is particularly common in pregnancy due to elevated estrogen levels, and recent antibiotic use (such as cephalexin) further disrupts normal vaginal flora, facilitating yeast overgrowth. For pregnant women, the Centers for Disease Control and Prevention (CDC) and the American College of Obstetricians and Gynecologists (ACOG) recommend topical vaginal azoles (such as clotrimazole or miconazole) applied for 7 days. These local therapies have minimal systemic absorption and are safe for the fetus.

Step-by-Step Solution

1
Evaluate the patient's symptoms and physical examination findings.
Intense vulvar pruritus, vulvar erythema, and a thick, curd-like vaginal discharge are identified.
These are the classic clinical hallmarks of vulvovaginal candidiasis (VVC).
2
Analyze the diagnostic test results (vaginal pH and wet mount).
The vaginal pH is normal (4.2), and the KOH preparation reveals budding yeasts and pseudohyphae.
A normal pH (<4.5) combined with the visualization of yeast forms confirms the diagnosis of VVC, effectively ruling out bacterial vaginosis and trichomoniasis.
3
Determine the appropriate pharmacotherapy given the patient's pregnant state.
Intravaginal clotrimazole for 7 days is selected.
During pregnancy, topical azoles applied for 7 days are the recommended first-line therapy, whereas systemic oral fluconazole is avoided due to potential teratogenic effects.

Key Concept

Vulvovaginal candidiasis in pregnancy should be treated with a 7-day course of a topical azole (e.g., clotrimazole) rather than oral fluconazole, which carries potential risks of fetal harm.
Question 827Question →

A 3131-year-old woman comes to the clinic for evaluation of amenorrhea. She has not had a menstrual period since the vaginal delivery of her first child 1414 months ago. Her pregnancy was complicated by placental abruption and severe postpartum hemorrhage that required emergency fluid resuscitation and a blood transfusion. The patient reports she was never able to produce breast milk despite multiple attempts to breastfeed. Over the past six months, she has also noted significant fatigue, a 1010-lb (4.54.5-kg) weight loss, and feeling cold all the time. On physical examination, blood pressure is 90/6090/60 mmHg and pulse is 5858/min. She has dry skin, sparse pubic hair, and delayed relaxation of deep tendon reflexes. A urine pregnancy test is negative.

Which of the following sets of laboratory test results is most likely in this patient?

Show answer & explanation

Answer: Decreased free T4, decreased TSH, decreased prolactin, and decreased FSH

Answer

The correct laboratory pattern is decreased free T4, decreased TSH, decreased prolactin, and decreased FSH.
The correct answer demonstrates a global decrease in anterior pituitary hormones. This patient's presentation of secondary amenorrhea, failure to lactate, and symptoms of hypothyroidism following a complicated delivery with severe postpartum hemorrhage is highly characteristic of Sheehan syndrome (postpartum pituitary gland necrosis). During pregnancy, the anterior pituitary gland enlarges and becomes highly vascular, making it vulnerable to ischemic necrosis in the setting of severe hypotension or hypovolemic shock (e.g., severe postpartum hemorrhage). Ischemic necrosis leads to panhypopituitarism. Loss of prolactin results in failure of lactation, which is often the earliest clinical symptom. Loss of gonadotropins (FSH and LH) leads to secondary amenorrhea. Loss of thyroid-stimulating hormone (TSH) leads to secondary hypothyroidism (evidenced by decreased free T4, fatigue, cold intolerance, bradycardia, and delayed deep tendon reflexes). Loss of adrenocorticotropic hormone (ACTH) leads to secondary adrenal insufficiency, presenting with weight loss, hypotension, and sparse pubic hair (due to decreased adrenal androgens). Therefore, laboratory testing would show a decrease in anterior pituitary hormones (TSH, prolactin, FSH) and their downstream target hormones (such as free T4).

Step-by-Step Solution

1
Identify the primary presentation and relevant obstetric history.
The patient presents with secondary amenorrhea and failure of lactation following a severe postpartum hemorrhage.
Recognizing the connection between postpartum hemorrhage and subsequent amenorrhea is key to identifying the underlying etiology.
2
Evaluate the associated systemic symptoms and physical examination findings.
The patient exhibits signs of hypothyroidism (fatigue, cold intolerance, bradycardia, delayed reflexes) and adrenal insufficiency (hypotension, weight loss, sparse pubic hair).
Systemic signs point to a generalized endocrine dysfunction rather than an isolated reproductive axis abnormality.
3
Synthesize the findings to determine the most likely diagnosis.
The combination of multiple anterior pituitary hormone deficiencies following obstetric hemorrhage indicates panhypopituitarism due to Sheehan syndrome.
Sheehan syndrome occurs due to ischemic necrosis of the enlarged pituitary gland during hypovolemic shock, leading to deficiency of all anterior pituitary hormones.
4
Predict the corresponding laboratory findings based on the diagnosis.
Because the anterior pituitary is infarcted, stimulating hormones (TSH, FSH, LH, ACTH, prolactin) and their downstream targets (free T4) will all be decreased.
A destructive pituitary lesion abolishes the entire hypothalamic-pituitary-end organ axis.

Key Concept

Sheehan syndrome (postpartum pituitary necrosis) presents with panhypopituitarism, causing secondary amenorrhea, failure to lactate, and secondary hypothyroidism/adrenal insufficiency due to global anterior pituitary hormone deficiency.
Question 828Question →

Match each intrapartum fetal heart rate (FHR) tracing description with its primary pathophysiologic mechanism.

Click a left item, then click its matching right item

Items

Abrupt decreases in FHR (onset to nadir < 30 seconds), not necessarily associated with contractions
Gradual decreases in FHR (onset to nadir ≥ 30 seconds), with the nadir occurring after the peak of the contraction
Gradual decreases in FHR (onset to nadir ≥ 30 seconds), with the nadir mirroring the peak of the contraction
Smooth, sine-wave-like undulating FHR baseline with a frequency of 3-5 cycles per minute and absent variability

Matches

Show answer & explanation

Answer

1) Abrupt decreases match with transient cord compression. 2) Gradual decreases delayed after the contraction peak match with uteroplacental insufficiency. 3) Gradual decreases mirroring the contraction match with fetal head compression. 4) Sinusoidal pattern matches with profound fetal anemia.
Correctly identifying fetal heart rate patterns requires evaluating the onset, depth, and timing relative to uterine contractions. Variable decelerations are abrupt and caused by cord compression. Late decelerations are gradual, delayed relative to contractions, and caused by uteroplacental insufficiency. Early decelerations are gradual, mirror contractions, and are caused by head compression. A sinusoidal pattern lacks variability and indicates severe fetal anemia.

Step-by-Step Solution

1
Analyze the first tracing description showing abrupt decreases (onset to nadir < 30 seconds).
Identified as variable decelerations.
Variable decelerations are characterized by their abrupt onset. They correspond to transient umbilical cord compression.
2
Analyze the second tracing description showing gradual decreases peaking after the uterine contraction.
Identified as late decelerations.
Late decelerations are defined by their delayed timing relative to contractions. They correspond to uteroplacental insufficiency and hypoxemia.
3
Analyze the third tracing description showing gradual decreases mirroring the uterine contraction.
Identified as early decelerations.
Early decelerations are symmetric to contractions. They correspond to fetal head compression causing a vagal response.
4
Analyze the fourth tracing description showing a sine-wave-like undulating baseline.
Identified as a sinusoidal pattern.
A sinusoidal pattern is distinct from normal baseline variability and specifically corresponds to severe fetal anemia.

Key Concept

Pathophysiology and recognition of intrapartum fetal heart rate decelerations and specific patterns.
Question 829Question →

A 26-year-old primigravida presents to the clinic for her initial prenatal visit at 6 weeks gestation. She is currently asymptomatic and has no significant past medical history. As part of her prenatal education, the physician discusses the expected anatomical and physiological changes she will experience. Arrange the following physiological adaptations and clinical findings in the chronological order they typically occur or reach their peak or nadir during a normal, uncomplicated pregnancy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Peak human chorionic gonadotropin (hCG) concentration (approx. 10 weeks), Fundus reaching the umbilicus (20 weeks), Systemic blood pressure nadir (24-28 weeks), and Peak plasma volume expansion (32-34 weeks).
A normal pregnancy is characterized by a highly predictable sequence of physiological adaptations. Early in the first trimester, hCG (produced by the syncytiotrophoblast) rises sharply to preserve the corpus luteum, peaking at approximately 10 weeks of gestation. As the fetus grows, the uterus enlarges predictably; by 20 weeks, the fundus can be palpated at the level of the maternal umbilicus. Hemodynamically, progesterone causes marked smooth muscle relaxation and decreased systemic vascular resistance, leading to a nadir in systemic blood pressure mid-pregnancy (approximately 24 to 28 weeks). Finally, maternal plasma volume, which undergoes a robust compensatory expansion to support the uteroplacental unit and prepare for delivery blood loss, reaches its maximum peak at 32 to 34 weeks.

Step-by-Step Solution

1
Determine the timing of the peak maternal serum hCG concentration.
Peak hCG occurs at approximately 10 weeks of gestation.
hCG is produced by the syncytiotrophoblast to maintain the corpus luteum in early pregnancy. After peaking at 10 weeks, the placenta assumes primary progesterone production, and hCG levels decline.
2
Determine the timing of the uterine fundus reaching the umbilicus.
The fundus reaches the umbilicus at 20 weeks of gestation.
Anatomical growth of the uterus is a predictable clinical milestone, with the symphysis pubis corresponding to 12 weeks and the umbilicus corresponding to 20 weeks.
3
Determine the timing of the maternal blood pressure nadir.
The blood pressure nadir occurs at 24 to 28 weeks of gestation.
Progesterone-mediated vasodilation outpaces early volume expansion, causing systemic vascular resistance and blood pressure to drop to their lowest levels mid-pregnancy before slowly returning to baseline.
4
Determine the timing of peak maternal plasma volume expansion.
Plasma volume expansion peaks at 32 to 34 weeks of gestation.
Plasma volume progressively increases by up to 50% to meet metabolic demands, plateauing in the late third trimester (32-34 weeks).

Key Concept

Chronological timeline of normal maternal physiological adaptations and clinical landmarks during pregnancy.
Question 830Question →

A multiparous patient at 38 weeks gestation with a history of poorly controlled asthma and chronic hypertension is admitted for induction of labor. Her cervical exam is 4 cm dilated, 80% effaced, and at -1 station. Fetal heart rate monitoring is reassuring. Following a successful vaginal delivery of a macrosomic infant, the patient develops heavy vaginal bleeding consistent with uterine atony. The physician must select an appropriate uterotonic agent while avoiding exacerbation of her underlying conditions. Match the following medications considered for postpartum hemorrhage to their distinct pharmacological properties, adverse effects, or absolute contraindications.

Click a left item, then click its matching right item

Items

Methylergonovine
Carboprost tromethamine
Misoprostol
Oxytocin

Matches

Show answer & explanation

Answer

Methylergonovine matches the ergot alkaloid contraindicated in hypertension. Carboprost matches the prostaglandin contraindicated in asthma. Misoprostol matches the prostaglandin causing transient pyrexia. Oxytocin matches the nonapeptide causing water intoxication.
Each uterotonic agent has a distinct mechanism and side effect profile that dictates its clinical use and absolute contraindications. Methylergonovine causes vasoconstriction (avoid in hypertension). Carboprost causes bronchoconstriction (avoid in asthma). Misoprostol causes transient pyrexia and diarrhea. Oxytocin has an antidiuretic effect (risk of water intoxication).

Step-by-Step Solution

1
Analyze Methylergonovine
Identified as an ergot alkaloid.
Ergot alkaloids induce smooth muscle contraction and vasoconstriction, making them dangerous in patients with hypertensive disorders.
2
Analyze Carboprost tromethamine
Identified as a prostaglandin F2-alpha analog.
It causes bronchoconstriction and is contraindicated in asthmatic patients.
3
Analyze Misoprostol
Identified as a prostaglandin E1 analog.
It frequently causes systemic side effects such as shivering and transient fever, but does not have absolute contraindications for asthma or hypertension.
4
Analyze Oxytocin
Identified as structurally related to vasopressin.
Due to its antidiuretic effect, high prolonged doses can lead to severe hyponatremia and water intoxication.

Key Concept

Pharmacologic management of postpartum hemorrhage relies on selecting uterotonic agents while avoiding absolute contraindications based on the patient's medical history (e.g., asthma, hypertension).
Estimated Time:1m 0s
Question 831Question →

A 31-year-old G2P2 patient is evaluated in the emergency department for sudden, severe left lower quadrant abdominal pain and profound chills that started 24 hours ago. Her most recent menstrual period ended three weeks ago, and she had a copper intrauterine device inserted four weeks ago. Vitals include a temperature of 38.9°C (102.0°F), a heart rate of 112/min, and a blood pressure of 110/70 mmHg. She is in visible distress. Arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for managing this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Obtain a urine beta-hCG test, 2) Perform a bimanual pelvic examination, 3) Obtain a transvaginal ultrasound, 4) Admit to the hospital for intravenous broad-spectrum antibiotic therapy, and 5) Proceed with image-guided percutaneous drainage if clinical improvement does not occur.
The correct sequence follows the standard diagnostic and therapeutic algorithm for acute pelvic pain and suspected tubo-ovarian abscess. First, a pregnancy test (beta-hCG) is universally required to rule out an ectopic pregnancy. Next, a pelvic examination is performed to identify physical signs of pelvic inflammatory disease (e.g., cervical motion tenderness) and to collect cultures. After clinical suspicion is established, a transvaginal ultrasound is the imaging modality of choice to visualize the adnexa and confirm a TOA. Once an unruptured TOA is identified, the standard first-line treatment is hospital admission for intravenous broad-spectrum antibiotics. Finally, invasive interventions such as percutaneous or surgical drainage are reserved for patients who fail to show clinical improvement (e.g., persistent fever, worsening pain) after 48 to 72 hours of medical management.

Step-by-Step Solution

1
Rule out ectopic pregnancy.
Obtain a urine beta-hCG test.
Ectopic pregnancy must always be excluded first in reproductive-aged females with acute pelvic pain, especially those presenting with an intrauterine device.
2
Establish the clinical diagnosis of pelvic inflammatory disease (PID).
Perform a bimanual pelvic examination.
A physical examination confirms signs of PID, such as cervical motion and adnexal tenderness, which dictates the need for further imaging.
3
Assess for complications of PID.
Obtain a transvaginal ultrasound.
Imaging is indicated to evaluate for a tubo-ovarian abscess (TOA) and to rule out conditions requiring immediate surgery, such as ovarian torsion.
4
Initiate first-line therapy for an unruptured TOA.
Admit to the hospital for IV antibiotics.
Unruptured TOAs in stable patients are initially managed medically with inpatient parenteral broad-spectrum antibiotics.
5
Manage medical therapy failure.
Proceed with image-guided drainage.
Drainage is indicated only if the patient remains febrile or symptomatic after 48-72 hours of targeted IV antibiotic therapy.

Key Concept

Chronological evaluation and management of complicated pelvic inflammatory disease (PID) and tubo-ovarian abscess (TOA).
Question 832Question →

A 3434-year-old woman comes to the clinic for evaluation of severe vaginal itching and a thick, white vaginal discharge. She reports that this is her fourth such episode in the past 1010 months. For her prior episodes, she was treated with either an over-the-counter vaginal clotrimazole cream or a single dose of oral fluconazole, which completely resolved her symptoms each time. She has no history of diabetes mellitus, HIV, or immunosuppressant use. Her only medication is a combined oral contraceptive pill. Pelvic examination shows marked vulvar and vaginal erythema with adherent, cottage cheese-like discharge. Vaginal fluid analysis is performed:

TestResult
Vaginal pH4.04.0
Amine "whiff" testNegative
Saline wet mountNormal squamous epithelial cells, few leukocytes
KOH wet mountAbundant pseudohyphae and budding yeast

Which of the following is the most appropriate pharmacotherapy for this patient's current condition?

Show answer & explanation

Answer: Oral fluconazole every 7272 hours for 33 doses, followed by weekly oral fluconazole for 66 months

Answer

Oral fluconazole every 72 hours for 3 doses, followed by weekly oral fluconazole for 6 months
This patient has Recurrent Vulvovaginal Candidiasis (RVVC), clinically defined as four or more symptomatic episodes of vulvovaginal candidiasis within a 12-month period. The diagnostic findings of a normal vaginal pH (4.04.0), a negative whiff test, and the presence of pseudohyphae and budding yeast on KOH preparation definitively confirm the fungal etiology. While uncomplicated vulvovaginal candidiasis is effectively treated with a short course of topical azoles or a single dose of oral fluconazole, this approach is insufficient for RVVC. The standard of care for RVVC requires a biphasic approach: induction therapy followed by maintenance suppressive therapy. The recommended induction regimen is oral fluconazole (150150 mg) every 7272 hours for a total of 33 doses (days 1, 4, and 7). This must be immediately followed by maintenance therapy with oral fluconazole once weekly for 66 months to reliably prevent relapse.

Step-by-Step Solution

1
Analyze the patient's clinical history and presenting symptoms.
The patient presents with intense vaginal itching, thick white discharge, and reports ≥4\ge 4 episodes in the past 1212 months.
To identify the chronicity and defining characteristics of the current infectious episode.
2
Interpret the vaginal fluid analysis results.
Vaginal pH=4.0pH = 4.0 (normal), whiff test is negative, and KOH wet mount reveals pseudohyphae.
To definitively isolate the etiologic organism (Candida) and strictly exclude Bacterial Vaginosis or Trichomoniasis.
3
Synthesize findings to establish the specific diagnosis.
The diagnosis is Recurrent Vulvovaginal Candidiasis (RVVC).
RVVC is specifically defined by guidelines as 44 or more symptomatic episodes of vulvovaginal candidiasis within a 11-year timeframe.
4
Determine the appropriate, guideline-concordant treatment regimen.
Select oral fluconazole every 7272 hours for 33 doses (induction), followed by weekly fluconazole for 66 months (maintenance).
Standard short-course therapies are inadequate for RVVC; prolonged induction and suppressive maintenance are required to prevent relapse.

Key Concept

Recurrent vulvovaginal candidiasis (RVVC) is defined as 44 or more episodes in a 1212-month period and requires induction therapy (e.g., oral fluconazole every 7272 hours for 33 doses) followed by maintenance suppressive therapy (e.g., weekly oral fluconazole for 66 months).
Estimated Time:1m 15s
Question 833Question →

A 16-year-old girl is brought to the outpatient clinic due to the absence of menarche. She reports no cyclical pelvic or lower abdominal pain. Her medical history is unremarkable, and she takes no medications. On physical examination, her height is at the 60th percentile and weight is at the 55th percentile. Breast development and pubic hair are both at Tanner stage 4. Pelvic examination reveals normal external female genitalia, but there is a shortened, blind-ending vaginal pouch and the cervix cannot be visualized. Arrange the following steps in the most appropriate sequential order for the diagnostic evaluation and management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Pelvic ultrasound -> Serum karyotype and testosterone level -> Renal ultrasound -> Initiate therapy with progressive vaginal dilators.
The correct sequence follows the standard diagnostic algorithmic approach for primary amenorrhea. When physical examination reveals a blind-ending vagina, pelvic ultrasound is the initial required step to verify the absence of the uterus. Next, karyotype and testosterone levels differentiate the two main causes of an absent uterus: MRKH (46,XX) and CAIS (46,XY). After definitively confirming MRKH, screening for known associations (renal anomalies via ultrasound) must occur. Finally, treatment with vaginal dilators is offered when the patient is ready to engage in sexual activity.

Step-by-Step Solution

1
Perform a pelvic ultrasound
Confirms the anatomical absence of normal Mullerian structures (uterus, cervix, upper vagina).
It is the least invasive and most critical first imaging step to anatomically classify the cause of primary amenorrhea when a blind vagina is noted on physical exam.
2
Obtain a serum karyotype and testosterone level
Establishes the diagnosis of Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome vs Complete Androgen Insensitivity Syndrome (CAIS).
Both conditions present with an absent uterus and a blind vagina; karyotype (46,XX vs 46,XY) and testosterone levels (female vs male range) provide the definitive diagnosis.
3
Perform a renal ultrasound
Screens for associated urologic congenital anomalies.
Patients with MRKH have a high incidence (25-30%) of renal anomalies, such as unilateral renal agenesis or a horseshoe kidney, requiring screening upon diagnosis.
4
Initiate therapy with progressive vaginal dilators
Creates a functional neovagina.
Non-surgical dilation is the first-line and preferred treatment for vaginal agenesis, prioritized over surgical creation, and is started once diagnosis and screening are complete.

Key Concept

Evaluation of primary amenorrhea with normal breast development and an absent uterus requires sequential anatomical confirmation (ultrasound), genetic/endocrine diagnosis (karyotype/testosterone), screening for associated anomalies (renal ultrasound), and non-surgical management (vaginal dilators).
Question 834Question →

A 31-year-old woman, gravida 2, para 1, presents to the office for a scheduled prenatal evaluation at 32 weeks gestation. She reports feeling well, with appropriate fetal movement and no abdominal pain, itching, nausea, or vomiting. Her prior pregnancy was uncomplicated and resulted in a spontaneous vaginal delivery at term. Vital signs are within normal limits. Physical examination reveals a gravid uterus consistent with dates and normal fetal heart tones. She recently participated in an employer-sponsored health screening program and brings the laboratory report for review. The results show:

Laboratory ParameterValueReference Range (Nonpregnant)
Hemoglobin11.2 g/dL12.0–16.0 g/dL
Platelets180,000/mm³150,000–400,000/mm³
Aspartate aminotransferase (AST)18 U/L8–20 U/L
Alanine aminotransferase (ALT)22 U/L8–20 U/L
Alkaline phosphatase (ALP)310 U/L40–120 U/L
Total bilirubin0.6 mg/dL0.1–1.0 mg/dL

Which of the following is the most appropriate management regarding these laboratory findings?

Show answer & explanation

Answer: Continue standard prenatal monitoring without further hepatic testing

Answer

Continue standard prenatal monitoring without further hepatic testing
The correct management is to continue routine prenatal care without additional hepatic testing. During normal pregnancy, the placenta produces a heat-stable isozyme of alkaline phosphatase (ALP) that enters the maternal bloodstream. This typically results in a 2- to 4-fold increase in total serum ALP levels, peaking in the third trimester. Because this patient is entirely asymptomatic and her other hepatic markers (AST, ALT, and total bilirubin) are strictly within normal limits, this isolated elevation represents a well-recognized and benign physiologic adaptation to pregnancy. No further evaluation is indicated.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient is an asymptomatic pregnant woman at 32 weeks gestation with no complaints of right upper quadrant pain, jaundice, or pruritus.
Establishing the presence or absence of symptoms is critical for differentiating physiologic changes from pathologic conditions like cholestasis or gallstone disease.
2
Interpret the laboratory findings.
The patient has an isolated elevation of alkaline phosphatase (ALP) at nearly three times the nonpregnant upper limit of normal, with normal hemoglobin, platelets, AST, ALT, and bilirubin.
Pattern recognition of hepatic panels helps narrow the differential diagnosis. An isolated ALP elevation in late pregnancy is distinct from a transaminitis.
3
Correlate the laboratory data with normal physiologic adaptations of pregnancy.
The placenta produces a specific heat-stable isozyme of alkaline phosphatase, which enters the maternal circulation and causes total serum ALP levels to normally rise 2- to 4-fold during the late second and third trimesters.
Recognizing this physiologic process prevents the misdiagnosis of hepatobiliary disease.
4
Determine the appropriate management.
Because the clinical picture represents a normal, expected finding in pregnancy, no additional diagnostic workup or medical intervention is required.
Unnecessary testing in asymptomatic patients with expected physiologic changes increases healthcare costs and patient anxiety.

Key Concept

During the late second and third trimesters of a normal pregnancy, total serum alkaline phosphatase (ALP) levels physiologically increase 2- to 4-fold due to the production of a placental ALP isozyme.
Question 835Question →

An expectant mother at 22 weeks gestation is evaluated in the obstetric clinic. The 28-year-old nulliparous patient mentions newly noticed ankle swelling that worsens by the evening and feeling slightly winded when walking up the stairs to her apartment. She denies paroxysmal nocturnal dyspnea, chest pain, syncope, or palpitations. Her past medical history is unremarkable, and she takes only a daily prenatal vitamin. Vital signs show a temperature of 37.0°C (98.6°F), blood pressure of 108/68 mm Hg, pulse of 86/min, and respirations of 16/min. Cardiac auscultation reveals a grade 2/6 early systolic ejection murmur heard best at the left upper sternal border and a distinct S3 gallop. Pulmonary auscultation is clear bilaterally. There is trace pitting edema of both ankles. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassurance and continuation of routine prenatal care

Answer

Reassurance and continuation of routine prenatal care
The correct answer is reassurance and continuation of routine prenatal care. This patient's symptoms and physical examination findings are classic for the normal physiologic adaptations of pregnancy. During pregnancy, maternal plasma volume expands by up to 50%, leading to increased cardiac output and a hyperdynamic circulation. This high-flow state commonly produces a benign grade 1/6 to 2/6 early or mid-systolic ejection murmur and a third heart sound (S3). Progesterone also stimulates the medullary respiratory center, causing an increase in minute ventilation that many pregnant patients perceive as mild dyspnea, despite having clear lungs and normal oxygenation. Furthermore, the enlarging gravid uterus compresses the inferior vena cava, increasing venous hydrostatic pressure in the lower extremities and leading to trace-to-mild dependent pitting edema. Because all of these changes are expected and benign, no further workup is indicated.

Step-by-Step Solution

1
Analyze the patient's symptoms and vital signs.
The patient has mild exertional dyspnea and dependent edema with normal vital signs for pregnancy (mildly decreased BP is expected in the second trimester).
Establishing the clinical stability of the patient helps differentiate benign adaptations from pathologic states.
2
Interpret the physical examination findings.
The grade 2/6 systolic ejection murmur and S3 gallop in the setting of clear lungs indicate a high-flow state without heart failure.
Pregnancy induces a hyperdynamic circulation due to significantly increased plasma volume and cardiac output.
3
Determine the appropriate management.
Since all findings are part of normal pregnancy physiology, no diagnostic testing or pharmacologic intervention is required.
Medical interventions or extensive testing for benign physiologic changes can cause unnecessary anxiety and potential harm.

Key Concept

Normal cardiovascular and respiratory physiologic adaptations during pregnancy
Estimated Time:1m 15s
Question 836Question →

A clinical pathway coordinator is updating the standard operating procedures for a community obstetrics practice. They are mapping out the anticipated schedule of evaluations for healthy patients presenting with an uncomplicated singleton pregnancy in the first trimester. Arrange the following routine prenatal screening evaluations in the correct chronological order from earliest gestational age to latest gestational age.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: First-trimester combined screening (11-14 weeks), followed by the comprehensive fetal anatomic survey (18-22 weeks), then the 50-gram 1-hour oral glucose challenge test (24-28 weeks), and finally the rectovaginal swab for Group B Streptococcus (36-37 6/7 weeks).
The established sequence of routine prenatal care follows fetal development and physiologic maternal changes: first-trimester aneuploidy screening is conducted between 11-14 weeks; the comprehensive anatomic evaluation is performed at 18-22 weeks; the oral glucose challenge test is universally administered at 24-28 weeks; and GBS rectovaginal screening is carried out at 36-37 6/7 weeks.

Step-by-Step Solution

1
Determine the timing for first-trimester combined screening.
Performed at 11 to 14 weeks.
This is the strictly established window during which the fetal nuchal translucency space can be accurately measured and correlated with specific serum analytes.
2
Determine the timing for the fetal anatomy scan.
Performed at 18 to 22 weeks.
By this gestational age, fetal organogenesis is complete and structures are sufficiently developed to be evaluated for major morphologic anomalies.
3
Determine the timing for gestational diabetes screening.
Performed at 24 to 28 weeks.
Human placental lactogen and other diabetogenic hormones peak in the late second and early third trimesters, making this the optimal window to detect maternal insulin resistance.
4
Determine the timing for Group B Streptococcus screening.
Performed at 36 0/7 to 37 6/7 weeks.
Because colonization status can fluctuate, swabbing within 5 weeks of anticipated delivery provides the most accurate prediction of status at the onset of labor.

Key Concept

Routine prenatal care requires a standardized chronological timeline to accurately assess fetal development and maternal adaptations, ensuring screenings are performed when they yield the highest diagnostic sensitivity and predictive value.
Question 837Question →

A 59-year-old nulliparous female presents to her gynecologist with new-onset vaginal bleeding. She has a history of type 2 diabetes mellitus and a body mass index of 42. Arrange the following steps in the standard chronological sequence for the evaluation and definitive management of her most likely condition, from initial diagnostic testing to post-surgical care.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Endometrial biopsy, followed by Magnetic resonance imaging (MRI) of the pelvis, then Total extrafascial hysterectomy with bilateral salpingo-oophorectomy, and finally Adjuvant pelvic radiation therapy.
In a postmenopausal patient presenting with vaginal bleeding and a high risk for endometrial cancer (obesity, nulliparity, diabetes), the first mandatory step is histologic evaluation via an endometrial biopsy. Once the cancer is confirmed, pelvic MRI is often utilized to assess myometrial invasion and aid in surgical planning. The mainstay of treatment is surgical staging, which includes a total extrafascial hysterectomy and bilateral salpingo-oophorectomy. Finally, adjuvant treatments like pelvic radiation are considered and administered postoperatively if the surgical pathology reveals advanced local stage or high-risk features.

Step-by-Step Solution

1
Identify the primary clinical presentation and associated risk factors.
The patient is a postmenopausal woman with new-onset vaginal bleeding, nulliparity, and severe obesity, making endometrial carcinoma the most likely suspected diagnosis.
Postmenopausal bleeding requires immediate evaluation to rule out malignancy, especially in patients with prolonged unopposed estrogen exposure.
2
Determine the first appropriate diagnostic intervention.
Endometrial biopsy is indicated first.
Office-based endometrial sampling is the preferred initial modality to obtain tissue for a definitive histologic diagnosis prior to any major intervention.
3
Establish the next step after tissue confirmation of malignancy.
Magnetic resonance imaging (MRI) of the pelvis.
Once an endometrial malignancy is confirmed, imaging aids in preoperative planning by precisely assessing disease extent, such as local cervical spread or deep myometrial invasion.
4
Identify the definitive primary surgical treatment.
Total extrafascial hysterectomy with bilateral salpingo-oophorectomy.
This procedure, often accompanied by lymph node assessment, serves as both the definitive oncologic treatment and the surgical staging method.
5
Determine the final potential step in the management pathway.
Adjuvant pelvic radiation therapy.
Depending on the formal surgical staging and pathologic findings, postoperative radiation may be indicated to reduce the risk of local recurrence in high-risk patients.

Key Concept

The standard diagnostic and therapeutic pathway for endometrial cancer involves tissue diagnosis, preoperative staging imaging, definitive surgical resection, and potential postoperative adjuvant therapy.
Question 838Question →

During a busy night shift on the labor and delivery unit, a 3232-year-old multiparous woman (G3P2) at 4040 weeks of gestation successfully delivers a 41004100 g neonate vaginally. Shortly after the third stage of labor concludes with the delivery of an intact placenta, the patient experiences a sudden, massive gush of vaginal blood. Abdominal palpation reveals a soft, poorly contracted uterus extending above the umbilicus. Assuming each intervention fails to arrest the hemorrhage, arrange the following clinical management steps in their standard procedural sequence from least invasive to most definitive.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing refractory postpartum hemorrhage escalates from first-line medical therapy (bimanual massage and oxytocin) to second-line medical therapy (e.g., methylergonovine, carboprost), then to mechanical intervention (intrauterine balloon tamponade), followed by conservative surgical intervention (compression sutures), and finally definitive surgical intervention (hysterectomy).
The algorithm for postpartum hemorrhage strictly dictates starting with the least invasive, fastest interventions (massage and oxytocin). When the uterus remains unresponsive, additional pharmacologic agents (carboprost, methylergonovine) are utilized. If the atony is refractory to medications, mechanical pressure via an intrauterine balloon is applied. Surgical intervention is reserved for failures of all aforementioned methods, initially attempting uterine-sparing compression sutures before resorting to a definitive hysterectomy.

Step-by-Step Solution

1
Identify the etiology of the postpartum hemorrhage.
The presence of a soft, boggy uterus palpated above the umbilicus confirms uterine atony.
Uterine atony is the most common cause of postpartum hemorrhage and follows a highly specific treatment algorithm.
2
Order the sequence beginning with the least invasive primary therapies.
Bimanual massage and oxytocin are placed first.
These standard initial measures effectively treat the vast majority of atony cases with minimal risk.
3
Identify the next escalation if primary therapies fail.
Secondary uterotonics are placed second.
Pharmacological options must be maximized before proceeding to mechanical or invasive procedures.
4
Transition to non-pharmacological, non-surgical methods.
Intrauterine balloon tamponade is placed third.
This offers a highly effective, minimally invasive way to tamponade the bleeding without exposing the patient to the morbidity of a laparotomy.
5
Determine the surgical escalation pathway.
Laparotomy with compression sutures is placed fourth, and hysterectomy is placed fifth.
Conservative surgery is always attempted first to preserve fertility, with hysterectomy strictly reserved as a last resort.

Key Concept

Stepwise escalation algorithm for the management of postpartum hemorrhage due to uterine atony
Estimated Time:1m 30s
Question 839Question →

Match each patient's clinical presentation with the most likely etiologic pathogen and its corresponding expected microscopic findings.

Click a left item, then click its matching right item

Items

A 26-year-old woman presents with a thin, homogeneous, grayish-white vaginal discharge and a positive amine whiff test. Vaginal pH is 5.5.
A 30-year-old woman reports severe vulvar pruritus and a thick, clumpy, white vaginal discharge. Vaginal pH is 4.0.
A 22-year-old woman presents with a frothy, yellow-green vaginal discharge and punctate macular hemorrhages on the cervix. Vaginal pH is 6.0.
A 28-year-old woman presents with postcoital bleeding and a mucopurulent cervical discharge. The cervix is friable upon examination. Vaginal pH is 4.2.

Matches

Show answer & explanation

Answer

The correct matches align each distinct clinical presentation with its causative organism and classic microscopic findings: the thin grayish discharge (BV) matches with Gardnerella/clue cells; the thick white discharge (Candidiasis) matches with Candida/pseudohyphae; the frothy green discharge (Trichomoniasis) matches with Trichomonas/motile organisms; and the mucopurulent discharge with a normal pH (Cervicitis) matches with Chlamydia/leukocytes.
Each vignette provides classic discriminators for common gynecologic infections. A thin grayish discharge with a pH > 4.5 and a positive amine test defines Bacterial Vaginosis (Gardnerella, clue cells). Severe pruritus, a thick white discharge, and normal pH (< 4.5) defines Candidiasis (pseudohyphae). A frothy green discharge with an elevated pH and a 'strawberry cervix' indicates Trichomoniasis (motile protozoa). Finally, a mucopurulent discharge and friable cervix with a normal pH suggests Cervicitis (Chlamydia, leukocytes).

Step-by-Step Solution

1
Analyze the first clinical vignette (thin discharge, pH 5.5, positive whiff test).
Identified as Bacterial Vaginosis (BV).
These findings meet 3 of the 4 Amsel criteria for BV.
2
Identify the microscopic finding for BV.
Clue cells (epithelial cells with blurred margins) due to Gardnerella vaginalis.
Bacterial adherence to epithelial cells is the microscopic hallmark of this dysbiosis.
3
Analyze the second clinical vignette (thick discharge, pH 4.0, pruritus).
Identified as Vulvovaginal Candidiasis.
The normal pH (3.8-4.5) and thick white discharge point to a yeast infection.
4
Identify the microscopic finding for Candidiasis.
Pseudohyphae and budding yeast.
A KOH preparation lyses epithelial cells, allowing clear visualization of Candida.
5
Analyze the third clinical vignette (frothy green discharge, pH 6.0, cervical petechiae).
Identified as Trichomoniasis.
The combination of significantly elevated pH, frothy discharge, and 'strawberry cervix' is highly specific.
6
Identify the microscopic finding for Trichomoniasis.
Motile flagellated protozoa.
Trichomonas vaginalis is a motile organism directly visible on a saline wet mount.
7
Analyze the fourth clinical vignette (mucopurulent discharge, normal pH, friable cervix).
Identified as Acute Cervicitis.
A friable cervix with purulent discharge and a normal vaginal pH indicates inflammation of the cervix rather than vaginitis.
8
Identify the microscopic finding for Cervicitis.
Abundant leukocytes without visible vaginal pathogens.
Chlamydia trachomatis is an intracellular organism and will not be seen on a standard wet mount, but the resulting cervical inflammation produces numerous leukocytes.

Key Concept

Differential diagnosis of vaginitis and cervicitis utilizes clinical findings (discharge characteristics, vaginal pH, cervical appearance) and direct microscopy to identify the causative organism.
Question 840Question →

Match each characteristic histological or clinical presentation of a gynecologic neoplasm with its most closely associated serum tumor marker.

Click a left item, then click its matching right item

Items

An ovarian neoplasm characterized by sheets of uniform cells with clear cytoplasm and central nuclei, separated by fibrous septa containing a lymphocytic infiltrate.
An aggressive germ cell tumor characterized histologically by Schiller-Duval bodies, which are papillary structures resembling primitive glomeruli.
A malignant epithelial ovarian tumor frequently presenting with bilateral complex cystic masses; histology demonstrates papillary structures and concentric calcified concretions.
A hormonally active ovarian tumor in a postmenopausal woman presenting with vaginal bleeding and endometrial hyperplasia; histology reveals Call-Exner bodies.

Matches

Show answer & explanation

Answer

Dysgerminoma matches with LDH, Yolk sac tumor matches with AFP, Serous cystadenocarcinoma matches with CA-125, and Granulosa cell tumor matches with Inhibin.
Each ovarian tumor type has a distinct embryologic origin, histological appearance, and biochemical profile. Recognizing the unique combinations (e.g., Schiller-Duval bodies with AFP, or Call-Exner bodies with Inhibin) is essential for correct classification and subsequent management.

Step-by-Step Solution

1
Identify the tumor described by clear cells and lymphocytic infiltrates.
Dysgerminoma, which corresponds to elevated Lactate dehydrogenase (LDH).
Dysgerminoma is a germ cell tumor with classic 'fried egg' appearance on histology and commonly secretes LDH.
2
Identify the tumor characterized by Schiller-Duval bodies.
Yolk sac tumor, which corresponds to elevated Alpha-fetoprotein (AFP).
Schiller-Duval bodies are pathognomonic for yolk sac tumors, which are associated with very high serum AFP levels.
3
Identify the bilateral tumor with psammoma bodies.
Serous cystadenocarcinoma, which corresponds to Cancer antigen 125 (CA-125).
Epithelial ovarian cancers, such as serous cystadenocarcinomas, typically produce CA-125, which is used for monitoring.
4
Identify the estrogen-producing tumor with Call-Exner bodies.
Granulosa cell tumor, which corresponds to Inhibin.
Granulosa cell tumors are sex cord-stromal tumors that secrete inhibin and estrogen, leading to symptoms like postmenopausal bleeding.

Key Concept

Diagnosis and monitoring of ovarian neoplasms rely heavily on specific serum tumor markers correlated with histological findings.
Estimated Time:1m 30s
PreviousPage 42 / 53Next